Home/Filings/4/0001062993-20-004523
4//SEC Filing

Breton Jose 4

Accession 0001062993-20-004523

CIK 0000819050other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:19 PM ET

Size

9.2 KB

Accession

0001062993-20-004523

Insider Transaction Report

Form 4
Period: 2020-09-15
Breton Jose
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-09-15+150,000150,000 total
    Exercise: $0.80Exp: 2030-09-15Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001784373

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:19 PM ET
Size
9.2 KB